rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-2-7
|
pubmed:databankReference |
|
pubmed:abstractText |
Elevated plasma homocysteine levels are reported to be associated with higher rates of vascular diseases. Plasma homocysteine increases in chronic kidney disease (CKD) and could contribute to the increased cardiovascular risk in CKD.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1460-2385
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
645-53
|
pubmed:meshHeading |
pubmed-meshheading:18003666-Aged,
pubmed-meshheading:18003666-Double-Blind Method,
pubmed-meshheading:18003666-Drug Therapy, Combination,
pubmed-meshheading:18003666-Female,
pubmed-meshheading:18003666-Folic Acid,
pubmed-meshheading:18003666-Homocysteine,
pubmed-meshheading:18003666-Humans,
pubmed-meshheading:18003666-Kidney Failure, Chronic,
pubmed-meshheading:18003666-Male,
pubmed-meshheading:18003666-Vitamin B 12,
pubmed-meshheading:18003666-Vitamin B 6
|
pubmed:year |
2008
|
pubmed:articleTitle |
Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.
|
pubmed:affiliation |
Department of Medicine, Munich General Hospitals and KfH Kidney Centre, Munich, Germany. johannes.mann@kms.mhn.de
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|